FOCUS Investment Banking Represents Vista Eye Specialists in its Sale to Atlantic Vision Partners, LLC

By |February 11, 2022|Deals, Healthcare|

Washington, DC, (February 14, 2022) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, divestiture, and corporate finance services, announced today that Vista Eye Specialists, an ophthalmologic and optomet- ric practice, has been acquired by Atlantic Vision Partners (“AVP”), a portfolio company of Sheridan Capital Partners. FOCUS managing directors, Eric Yetter and Andy Snyder, advised Vista Eye Specialists in this partnership.They are among the most active advisors to ophthal- mologists in transactions with private equity-backed organizations.

FOCUS Investment Banking Represents Velmed, Inc. in its Sale to Canadian Hospital Specialties Ltd.

By |January 28, 2022|Deals, Mergers & Acquisitions News, Mergers, Acquisitions & Divestitures|

Washington, DC, (January 27, 2022) – FOCUS Investment Banking (“FOCUS”), a national middle market investment banking firm providing merger, acquisition, dives- titure, and corporate finance services, announced today that Velmed, Inc. (“Velmed”), a South Carolina-based manufacturer of medical devices for the operating room and sterile processing department, has been acquired by Canadian Hospital Specialties Limited (“CHS”), a portfolio company of Flexpoint Ford, LLC. FOCUS advised Velmed in this transaction.

Dermatology – Q4 2021 Acquisition Activity and Outlook

By |January 18, 2022|Dermatology, Healthcare|

Dermatology Acquisitions Reach Peak Levels; Schweiger Dermatology Closes on Major Acquisition

The fourth quarter of 2021 delivered seventeen reported dermatology practice acquisitions, representing a significant surge to end the year. There were two large practice acquisitions as well as a major platform recapitalization announcement.

Behavioral Health – Q4 2021 Acquisition Activity and Outlook

By |January 18, 2022|Behavioral Health, Healthcare|

Behavioral Health Acquisitions Peak at Year End: Mental Health and Addiction are Top Consolidators

The fourth quarter of 2021 delivered forty-two reported behavioral health acquisitions, reaching a new peak level for the 2021 calendar year. Mental health and addiction treatment continues to be at the forefront of consolidation. A few notable deals from the period are highlighted below.

ENT & Allergy – Q3 2021 Acquisition Activity and Outlook

By |October 15, 2021|ENT & Allergy, Healthcare|

After a Quiet Quarter for ENT & Allergy Practice Acquisitions, We See Increasing Opportunity in Q4

The third quarter of 2021 delivered one major reported ENT practice acquisition, still far below the peak of activity in Q1. In September, an investment from The Beekman Group formed a partnership with Allergy & ENT Associates, a management services organization that supports a network of sixteen ENT clinics in the Greater Houston area.

Dermatology – Q3 2021 Acquisition Activity and Outlook

By |October 15, 2021|Dermatology, Healthcare|

Dermatology Acquisitions Continue to Increase in Q3 as Established Players Pursue Expansion

The third quarter of 2021 delivered eight reported dermatology practice acquisitions, showing an increasing trend of deal volume over the past nine months. Notably, Pinnacle Dermatology acquired Dermatology Associates and Skin Surgery Center which includes eight locations throughout West Virginia and Maryland.
Go to Top